Scholand K, Schaefer L, Govindarajan G, Yu Z, Galletti J, de Paiva C
Geroscience. 2025; .
PMID: 40053297
DOI: 10.1007/s11357-025-01576-y.
Zhu Y, Lu Z, Wang Z, Liu J, Ning K
Front Immunol. 2025; 16:1480496.
PMID: 39958351
PMC: 11825815.
DOI: 10.3389/fimmu.2025.1480496.
Faliti C, Mesina M, Choi J, Belanger S, Marshall M, Tipton C
Immunity. 2024; 57(12):2772-2789.e8.
PMID: 39612915
PMC: 11675998.
DOI: 10.1016/j.immuni.2024.11.006.
Huo M, Adeerjiang Y, Abulitipu A, Khan U, Li X, Zhang L
Front Oncol. 2024; 14:1325575.
PMID: 39534095
PMC: 11554530.
DOI: 10.3389/fonc.2024.1325575.
Adejumo I
Genes Nutr. 2024; 19(1):21.
PMID: 39425027
PMC: 11490116.
DOI: 10.1186/s12263-024-00755-4.
CD38 in SLE CD4 T cells promotes Ca flux and suppresses interleukin-2 production by enhancing the expression of GM2 on the surface membrane.
Katsuyama E, Humbel M, Suarez-Fueyo A, Satyam A, Yoshida N, Kyttaris V
Nat Commun. 2024; 15(1):8304.
PMID: 39333474
PMC: 11436706.
DOI: 10.1038/s41467-024-52617-7.
Inhibition of Cathepsin S in Autoimmune CD25KO Mouse Improves Sjögren Disease-Like Lacrimal Gland Pathology.
Scholand K, Galletti J, Haap W, Santos-Ferreira T, Ullmer C, de Paiva C
Invest Ophthalmol Vis Sci. 2024; 65(8):26.
PMID: 39017634
PMC: 11262477.
DOI: 10.1167/iovs.65.8.26.
Spectrum of Treg and self-reactive T cells: single cell perspectives from old friend HTLV-1.
Ono M, Satou Y
Discov Immunol. 2024; 3(1):kyae006.
PMID: 38863793
PMC: 11165433.
DOI: 10.1093/discim/kyae006.
IL-2Rα KO mice exhibit maternal microchimerism and reveal nuclear localization of IL-2Rα in lymphoid and non-lymphoid cells.
Wong V, Dinh K, Chen G, Wrenshall L
Front Immunol. 2024; 15:1369818.
PMID: 38812502
PMC: 11133634.
DOI: 10.3389/fimmu.2024.1369818.
Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer.
Shouse A, LaPorte K, Malek T
Immunity. 2024; 57(3):414-428.
PMID: 38479359
PMC: 11126276.
DOI: 10.1016/j.immuni.2024.02.001.
A single-agent fusion of human IL-2 and anti-IL-2 antibody that selectively expands regulatory T cells.
Lin Y, Wang X, Qin Y, Wang C, Zhou T, Zhang L
Commun Biol. 2024; 7(1):299.
PMID: 38461332
PMC: 10925001.
DOI: 10.1038/s42003-024-05987-z.
The T-Cell Growth Factor Interleukin-2, Which Is Occasionally Targeted by Autoantibodies, Qualifies as Drug for the Treatment of Allergy, Autoimmunity, and Cancer: Collegium Internationale Allergologicum (CIA) Update 2024.
Sehgal A, Tauber P, Stieger R, Kratzer B, Pickl W
Int Arch Allergy Immunol. 2023; 185(3):286-300.
PMID: 38086339
PMC: 10911178.
DOI: 10.1159/000533677.
Molecular and temporal control of restimulation-induced cell death (RICD) in T lymphocytes.
Lee K, Epstein B, Lake C, Snow A
Front Cell Death. 2023; 2.
PMID: 38074985
PMC: 10705843.
DOI: 10.3389/fceld.2023.1281137.
Molecular Engineering of Interleukin-2 for Enhanced Therapeutic Activity in Autoimmune Diseases.
Tomasovic L, Liu K, VanDyke D, Fabilane C, Spangler J
BioDrugs. 2023; 38(2):227-248.
PMID: 37999893
PMC: 10947368.
DOI: 10.1007/s40259-023-00635-0.
"IL-2 immunotherapy for targeting regulatory T cells in autoimmunity".
Lykhopiy V, Malviya V, Humblet-Baron S, Schlenner S
Genes Immun. 2023; 24(5):248-262.
PMID: 37741949
PMC: 10575774.
DOI: 10.1038/s41435-023-00221-y.
Conditional deletion of CD25 in the corneal epithelium reveals sex differences in barrier disruption.
Abu-Romman A, Scholand K, Pal-Ghosh S, Yu Z, Kelagere Y, Yazdanpanah G
Ocul Surf. 2023; 30:57-72.
PMID: 37516317
PMC: 10812880.
DOI: 10.1016/j.jtos.2023.07.008.
Ivermectin Protects Against Experimental Autoimmune Encephalomyelitis in Mice by Modulating the Th17/Treg Balance Involved in the IL-2/STAT5 Pathway.
Xie Y, Jin C, Sang H, Liu W, Wang J
Inflammation. 2023; 46(5):1626-1638.
PMID: 37227550
PMC: 10209955.
DOI: 10.1007/s10753-023-01829-y.
The small molecule inhibitor BX-795 uncouples IL-2 production from inhibition of Th2 inflammation and induces CD4 T cells resembling iTreg.
Tauber P, Kratzer B, Schatzlmaier P, Smole U, Kohler C, Rausch L
Front Immunol. 2023; 14:1094694.
PMID: 37090735
PMC: 10117943.
DOI: 10.3389/fimmu.2023.1094694.
Low-dose IL-2 enhances the generation of IL-10-producing immunoregulatory B cells.
Inaba A, Tuong Z, Zhao T, Stewart A, Mathews R, Truman L
Nat Commun. 2023; 14(1):2071.
PMID: 37045832
PMC: 10097719.
DOI: 10.1038/s41467-023-37424-w.
Mouse mammary tumor virus is implicated in severity of colitis and dysbiosis in the IL-10 mouse model of inflammatory bowel disease.
Armstrong H, Rahbari M, Park H, Sharon D, Thiesen A, Hotte N
Microbiome. 2023; 11(1):39.
PMID: 36869359
PMC: 9983191.
DOI: 10.1186/s40168-023-01483-4.